Jan. 5, 2012—Jeffrey Sosman, M.D., professor of Medicine at Vanderbilt-Ingram Cancer Center (VICC), has been named to a melanoma research Dream Team of cancer investigators supported by Stand Up To Cancer (SU2C) and the Melanoma Research Alliance (MRA). Sosman is among the Dream Team’s principal investigators who will work closely with the other principal clinical investigators to...
Jan. 5, 2012—Vanderbilt-Ingram Cancer Center patients, families and staff members recently placed messages of hope and requests for cancer research funds on a “Wall of Hope” at the Cancer Center. The American Cancer Society Cancer Action Network sponsored the “Wall of Hope” initiative and will send the messages to members of Tennessee’s congressional delegation.
Dec. 15, 2011—Jeffrey Sosman, professor of medicine at Vanderbilt-Ingram Cancer Center (VICC), has been named to a melanoma research Dream Team of cancer investigators supported by Stand Up To Cancer (SU2C) and the Melanoma Research Alliance. Sosman is among the Dream Team’s principal investigators who will work closely to write the genomic-driven clinical trials and will lead...
Oct. 28, 2011—The list of aging-associated proteins known to be involved in cancer is growing longer, according to research by investigators at Vanderbilt-Ingram Cancer Center and the National Institutes of Health.
Jul. 27, 2011—Vanderbilt University Medical Center, in conjunction with the Vanderbilt-Ingram Cancer Center, has been re-accredited as a CEO Cancer Gold Standard employer for 2011. The award is based on Vanderbilt’s efforts to help employees lead healthier lives, including activities that may help prevent cancer.
May. 17, 2011—Once again the Monroe Carell Children's Hospital at Vanderbilt was recognized by the "U.S. News and World Report' children's hospital rankings.
Mar. 3, 2011—A new online tool enables cancer patients and researchers to track the latest developments in personalized cancer medicine and connect with clinical research trials.